Abstract
This study investigates the efficacy of benign prostatic hyperplasia (BPH) treatment by prostate transurethral enucleation using a 2-μm laser. A total of 107 patients with BPH were treated by prostate transurethral enucleation using a RevoLix 2-μm laser surgery system. Bleeding volume, operation time, catheterization time, voiding situation, maximum urinary flow rate, and hospital stay were observed. The mean operation time was 74 min ± 12 min (range 45 to 150 min), the mean follow-up period was 2 to 6 months, the mean catheter time was 5 days, and the mean peak urinary flow rate increased from 6.3 ± 0.6 to 17.5 ± 1.5 mL/s. The International Prostate Symptom Score and quality of life significantly declined (p < 0.01). No significant differences were observed in the hemoglobin and blood electrolytes before and after operation. Prostate transurethral enucleation using a 2-μm laser is safe and efficient for BPH treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Uchida T, Ohori M, Soh S, Sato T, Iwamura M, Ao T, Koshiba K (1999) Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 53:98–105
AUA Practice Guidelines committee (2003) AUA guideline on management of benign prostatic hyperplasia. Chapter 1: diagnosis and treatment recommendations. J Urol 170:530–547
Hammadeh MY, Madaan S, Singh M, Philp T (2000) A 3-year follow-up of a prospective randomized trial comparing transurethral electrovaporization of the prostate with standard transurethral prostatectomy. BJU Int 86:648–651
Mattioli S, Mnuoz R, Racasens R, Berbegal C, Cortada J, Urmeneta JM, Teichmann H (2008) Treatment of benign prostatic hyperplasia with the Revolix laser. J Arch Esp Urol 61:1037–1043
Fitzpatrick JM, Mebust KW (2004) Minimally invasive and endoscopic management of benign prostatic hyperplasia. In: Walsh CW, Retik AB, Vaughan ED, Wein AJ (eds) Campbell’s urology, 8th edn. WB Saunders, Philadelphia, p 1402
Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M (2004) Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 172:616–619
Shingleton WB, Farabaugh P, May W (2002) Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 60:305–308
Hammadeh MY, Madaan S, Singh M, Philp T (2000) A 3-year follow-up of a prospective randomized trial comparing transurethral electrovaporization of the prostate with standard transurethral prostatectomy. BJU Int 86:648–651
Chen CH, Chiang PH, Lee WC, Chuang YC, Kang CH, Hsu CC, Lee WC, Chen YT, Cheng YT (2012) High-intensity diode laser in combination with bipolar transurethral resection of the prostate: a new strategy for the treatment of large prostates (>80 ml). Lasers Surg Med 44:699–704
Liu C, Zheng S, Li H, Xu K (2010) Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol 184:2440–2445
Carter A, Sells H, Speakman M, Ewings P, MacDonagh R, O’Boyle P (1999) A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 83:254–259
Hauser J, Iselin CE (2012) An innovative laser for the minimally invasive treatment of benign prostatic hyperplasia. Rev Med Suisse 8:2340–2343
Lee SH, Choi JI, Moon KY, Na W, Lee JB (2012) Holmium laser enucleation of the prostate: modified morcellation technique and results. Korean J Urol 53:779–784
Cho SY, Park S, Jeong MY, Ro YK, Son H (2012) 120W GreenLight High Performance System laser for benign prostate hyperplasia: 68 patients with 3-year follow-up and analysis of predictors of response. Urology 80:396–401
Xia SJ (2009) Two-micron (thulium) laser resection of the prostate-tangerine technique: a new method for BPH treatment. Asian J Androl 11:277–281
Bach T, Herrmann TR, Ganzer R, Burchardt M, Gross AJ (2007) RevoLix vaporesection of the prostate: initial results of 54 patients with a 1-year follow-up. World J Urol 25:257–262
Sun DC, Yang Y, Wei ZT, Hong BF, Zhang X (2010) Transurethral dividing vaporesection for the treatment of large volume benign prostatic hyperplasia using 2 micron continuous wave laser. Chin Med J 123:2370–2374
Gilling PJ, Kennett K, Das AK, Thompson D, Fraundorfer MR (1998) Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol 12:457
Acknowledgments
This study was supported by the Beijing Science and Technology research project (Z090507017709031).
Ethical Approval
All investigations were performed after informed consent for study participation was obtained from all patients. The study protocol was approved by the ethical committee of the General Hospital of the Air Force of the Chinese People’s Liberation Army.
Conflict of Interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guo, HQ., Zhou, GB., Liu, HM. et al. Benign Prostatic Hyperplasia Treatment by Transurethral Enucleation of the Prostate Using a 2-μm Laser. Indian J Surg 77 (Suppl 3), 1073–1076 (2015). https://doi.org/10.1007/s12262-014-1158-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-014-1158-7